This is a Validated Antibody Database (VAD) review about human CIP2A, based on 2 published articles (read how Labome selects the articles), using CIP2A antibody in all methods. It is aimed to help Labome visitors find the most suited CIP2A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CIP2A synonym: KIAA1524; p90
Santa Cruz Biotechnology
mouse monoclonal (2G10-3B5) |
| Santa Cruz Biotechnology CIP2A antibody (Santa Cruz, sc-80659) was used in immunocytochemistry on human samples at 1:50 (fig 4g), in western blot on human samples at 1:500 (fig 4e, 4f, 5j) and in immunohistochemistry - paraffin section on mouse samples (fig 2b, s1c). Cancer Res (2021) ncbi |
mouse monoclonal (2G10-3B5) |
| Santa Cruz Biotechnology CIP2A antibody (Santa Cruz, sc-80659) was used in western blot on human samples at 1:1000 (fig 2) and in western blot on mouse samples at 1:1000 (fig 2). Oncotarget (2015) ncbi |
Articles Reviewed
- Ventelä S, Sittig E, Mannermaa L, Mäkelä J, Kulmala J, Löyttyniemi E, et al. CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance. Oncotarget. 2015;6:144-58 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments